Correlation Between Vaccinex and Champions Oncology

Can any of the company-specific risk be diversified away by investing in both Vaccinex and Champions Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vaccinex and Champions Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Vaccinex and Champions Oncology, you can compare the effects of market volatilities on Vaccinex and Champions Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vaccinex with a short position of Champions Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vaccinex and Champions Oncology.

Diversification Opportunities for Vaccinex and Champions Oncology

-0.66

Correlation Coefficient

Vaccinex  Champions Oncology

Excellent diversification

The 3 months correlation between Vaccinex and Champions is -0.66. Overlapping area represents the amount of risk that can be diversified away by holding Vaccinex and Champions Oncology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Champions Oncology and Vaccinex is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vaccinex are associated (or correlated) with Champions Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Champions Oncology has no effect on the direction of Vaccinex i.e., Vaccinex and Champions Oncology go up and down completely randomly.

Pair Corralation between Vaccinex and Champions Oncology

Given the investment horizon of 90 days Vaccinex is expected to under-perform the Champions Oncology. In addition to that, Vaccinex is 2.24 times more volatile than Champions Oncology. It trades about -0.07 of its total potential returns per unit of risk. Champions Oncology is currently generating about 0.11 per unit of volatility. If you would invest  486.00  in Champions Oncology on September 30, 2024 and sell it today you would earn a total of  349.00  from holding Champions Oncology or generate 71.81% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Vaccinex  vs.  Champions Oncology

Vaccinex

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Vaccinex has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Champions Oncology

Risk-Adjusted Performance

14 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Champions Oncology are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. Even with relatively uncertain fundamental drivers, Champions Oncology reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Vaccinex and Champions Oncology

The main advantage of trading using opposite Vaccinex and Champions Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vaccinex position performs unexpectedly, Champions Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Champions Oncology will offset losses from the drop in Champions Oncology's long position.

The idea behind Vaccinex and Champions Oncology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.